BACE1 and Alzheimer disease: This finding is in line with most of the experimental evidence—mouse models of aging and AD—that indicates that intracellular effects of estrogens induce upregulation of BACE1 gene expression levels [32, 52], confirming the widely accepted notion that women bear higher vulnerability to AD [53, 54].